A Real-world, Multi-centre, Prospective, Non-interventional, Single-arm Study Investigating Glycaemic Control, Treatment Satisfaction and Adherence Associated With the Use of Insulin Icodec in People Living With Type 1 Diabetes
Status: Recruiting
Location: See all (35) locations...
Intervention Type: Drug
Study Type: Observational
SUMMARY
The study will look at how well insulin icodec controls blood sugar levels in participants who have never used it before. Participants with type 1 diabetes (T1D) will be treated with insulin icodec as prescribed to by their doctor, in accordance with usual clinical practice. This study will last for about 22 to 30 weeks.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Signed consent obtained before any study-related activities (study-related activities are any procedures related to recording of data according to the protocol).
• The decision to initiate treatment with commercially available insulin icodec has been made by the participant/legally acceptable representative (LAR) and the treating physician before and independently from the decision to include the participant in this study.
• Male or female, age greater than or equal to (≥) 18 years at the time of signing informed consent.
• Diagnosed with T1D ≥ 1 year before signing informed consent.
• Treated with multiple daily insulin injections (daily basal insulin analogue and bolus insulin analogue regimen) ≥ 6 months before signing informed consent.
• Available HbA1c value less than or equal to (≤) 90 days prior to the 'Initiation visit' (V1) or HbA1c measurement taken in relation with the 'Initiation visit' (V1) if in line with local clinical practice.
• Treatment naïve to once-weekly insulin prior to the 'Initiation Visit' (V1).
Locations
Other Locations
Germany
Zuckerpraxis Dr. Ewald Jammers
RECRUITING
Bramsche
Studiengesellschaft Dres. Könemann/Steinmann GbR
RECRUITING
Bünde
Diabeteszentrum-Do Dres. K U. Ch. Busch GbR
RECRUITING
Dortmund
Diabeteszentrum Duisburg-Mitte
RECRUITING
Duisburg
MVZ im Altstadt-Carree Fulda GmbH - Zentrum für klinische Studien
RECRUITING
Fulda
Gemeinschaftspraxis Dr. Martin Grüneberg
RECRUITING
Herne
Mesut Durmaz, Hof
RECRUITING
Hof
Dr. Carola Lüke
RECRUITING
Jerichow
Diabetespraxis Kiel
RECRUITING
Kiel
Praxis Am Oberen Tor - Dr. Simon-Wagner
RECRUITING
Lichtenfels
Diabetologie Dr. Eidenmüller
RECRUITING
Marburg
Dr. Bernhard Landers
RECRUITING
Mayen
Diabeteszentrum Bogenhausen
RECRUITING
München
Medicover Neu-Ulm MVZ
COMPLETED
Neu-ulm
Diabetespraxis Oranienburg
RECRUITING
Oranienburg
Hausärztliche und Diabetologische Praxis Pirna
RECRUITING
Pirna
Diabetesschwerpunktpraxis Dr. Martina Lange
RECRUITING
Rheinbach
Med.Versorgungszentrum Riesa-Dr. Bieler
RECRUITING
Riesa
Dr. med. Carsten Schürfeld, GZ-Vauban
COMPLETED
Saarlouis
Diabetespraxis Schorndorf Dr. Hensel
RECRUITING
Schorndorf
Praxis Dr. Zimmermann
RECRUITING
Sonsbeck
Endokrinologikum Ulm
RECRUITING
Ulm
Diabetespraxis Viersen
RECRUITING
Viersen
Italy
Azienda Ospedaliera Papa Giovanni XXIII
NOT_YET_RECRUITING
Bergamo
Azienda Ospedaliero-Universitaria Renato Dulbecco
RECRUITING
Catanzaro
AUSL Toscana Nord Ovest - Ospedali Riuniti di Livorno - Diabetologia e Malattie del Metabolismo
RECRUITING
Livorno
AUSL Toscana Nord Ovest - Cittadella della Salute Campo di Marte - Diabetologia Lucca e Valle del Serchio
RECRUITING
Lucca
Azienda Ospedaliera Luigi Sacco
NOT_YET_RECRUITING
Milan
Ospedale San Raffaele S.r.l. - Unità Clinica Endocrinologia
NOT_YET_RECRUITING
Milan
A.O.U. Università Studi della Campania Luigi Vanvitelli
NOT_YET_RECRUITING
Naples
Azienda Ospedaliera di Perugia;Ospedale S. Maria della Misericordia
NOT_YET_RECRUITING
Perugia
DIABETOLOGIA Ravenna AUSL della Romagna
RECRUITING
Ravenna
Universita Degli Studi Di Roma La Sapienza - Policlinico Umberto I Medicina Sperimentale
RECRUITING
Roma
Fondazione Policlinico Universitario Agostino Gemelli IRCCS - Dipartimento di scienze Mediche e Chirurgiche
RECRUITING
Rome
Azienda Sanitaria Locale Città di Torino - Ambulatorio Endocrinologia e Malattie Metaboliche
NOT_YET_RECRUITING
Turin
Contact Information
Primary
Novo Nordisk
clinicaltrials@novonordisk.com
(+1) 866-867-7178
Time Frame
Start Date:2025-08-28
Estimated Completion Date:2027-01-20
Participants
Target number of participants:245
Treatments
Insulin icodec
Participants with T1D will be treated with commercially available insulin icodec according to routine clinical practice at the discretion of the treating physician.